Effect of CDK8/19 kinase inhibitor SNX 631 on OV90 parental and anoikis resistant isogenic lines
RNA-seq (gene expression) · human · 31 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 31 samples: 8 conditions, mostly with about 4 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE309005_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1333704 and SRA study SRP626247. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 30 samples.
How we read this: 8 replicated groups read from 31 sample titles; they account for 30 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9258073 AnS DMSO-1 AnS DMSO
- GSM9258074 AnS DMSO-2 AnS DMSO
- GSM9258075 AnS DMSO-3 AnS DMSO
- GSM9258076 AnS SNX-1 AnS SNX
- GSM9258077 AnS SNX-2 AnS SNX
- GSM9258078 AnS SNX-3 AnS SNX
- GSM9258079 AnS SNX-4 AnS SNX
- GSM9258080 AnR DMSO-2 AnR DMSO
- GSM9258081 AnR DMSO-3 AnR DMSO
- GSM9258082 AnR DMSO-4 AnR DMSO
- GSM9258083 AnR DMSO-5 AnR DMSO
- GSM9258084 AnR SNX-1 AnR SNX
- GSM9258085 AnR SNX-2 AnR SNX
- GSM9258086 AR SNX-3
- GSM9258087 AnR SNX-4 AnR SNX
- GSM9258088 AnR DD-1 AnR DD
- GSM9258089 AnR DD-2 AnR DD
- GSM9258090 AnR DD-3 AnR DD
- GSM9258091 AnR DD-4 AnR DD
- GSM9258092 AnR DS-1 AnR DS
- GSM9258093 AnR DS-2 AnR DS
- GSM9258094 AnR DS-3 AnR DS
- GSM9258095 AnR DS-4 AnR DS
- GSM9258096 AnR SD-1 AnR SD
- GSM9258097 AnR SD-2 AnR SD
- GSM9258098 AnR SD-3 AnR SD
- GSM9258099 AnR SD-4 AnR SD
- GSM9258100 AnR-SS-1 AnR-SS
- GSM9258101 AnR-SS-2 AnR-SS
- GSM9258102 AnR-SS-3 AnR-SS
- GSM9258103 AnR-SS-4 AnR-SS
- GSE298925 ZBTB11 Depletion Targets Metabolic Vulnerabilities in K-Ras Inhibitor Resistant PDAC [Degrader RNA-seq] 48 samples shares inhibitor, resistant
- GSE333925 Gene expression profile of 31 RAS/RAF-wild-type colorectal cancer (CRC) stem-cell (SC) spheroids and 7 FGFR-inhibitor resistant CSC-SC spheroids 38 samples shares inhibitor, resistant
- GSE330358 CDK4-selective inhibitor AU2-94 for the treatment of advanced and therapy-resistant prostate cancer 36 samples shares inhibitor, resistant
- GSE325471 The CDK4/6 inhibitor dalpiciclib augments the antitumor efficacy of enzalutamide in preclinical models of castration-resistant prostate cancer through inhibition of MCM4-mediated DNA replication 12 samples shares inhibitor, resistant
- GSE279730 Gene expression analysis of prostate cancer cells resistant to CDK7 inhibitors 12 samples shares inhibitor, resistant
- GSE304126 CDK8 inhibition sequesters Med1 at EWS-FLI enhancers [RNA-Seq] 68 samples shares cdk8
- GSE319092 Integrated Multi-Omics and Interactome Analysis of CDK8 Inhibition Reveals Erythroid Differentiation Programs and BET Synergy in AML Stem-like Cells 135 samples shares cdk8
- GSE303028 CDK8 Inhibition Releases the Muscle Differentiation Blockade in Fusion-driven Alveolar Rhabdomyosarcoma 104 samples shares cdk8
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.